The CCDC is actively seeking areas where we can assist in the fight against the nefarious SARS-Cov2 disease currently taking hold around the world.
We’ve already started committing to research time and have noted several collaborative efforts.
At the CCDC we have been deeply saddened by the devastating impact that COVID-19 has had around the world. During these difficult times it has, however, been heart-warming to see the scientific community coming together to try to find a cure and a vaccine.
This poster explores the process and benefits of CSD Communications - the simple way to share crystallographic data without the need for an accompanying paper.
Elsevier have made available a collection of around 20,000 articles relating to COVID-19. These are available to download for free for text and data mining.
A question one might ask is; which of these articles have an associated CSD structure?
As the corona virus (COVID-19) pandemic continues, scientists around the world have set up virtual projects to collaborate, share knowledge, resources and data to support drug discovery.
The current COVID-19 outbreak is making more people work remotely, either by choice or by company or government policies - but with the right approaches, scientists around the world continue their research work.
Each year we hold User Group Meetings, or UGMs, as a chance to meet with scientists from all areas of industry and academia who are using our software. This quick summary outlines what happens on the day, and why you should attend if you haven't before.
Earlier this year, the Cambridge Crystallographic Data Centre (CCDC) was delighted to receive the news that we had been approved for CoreTrustSeal certification. This certification accredits the CCDC with providing trusted stewardship and access to data as judged against criteria established and endorsed by the wider research data community. It reinforces and reflects the faith that our depositors and partner organisations have shown in CCDC over the years to provide a trusted home for their data.
It has been known for over 100 years that some compounds can be added to a reaction to speed it up without being changed themselves – this is the principle of catalysis. The early years saw much of the research into the fundamental kinetics and industrial applications. This blog will highlight the advancements in catalytic science by looking at selected Nobel Prize winners,1 particularly for organic synthesis, and the contribution of catalysts to the Cambridge Structural Database (CSD).
I always like visiting the headquarters of the Royal Society of Chemistry at Burlington House. Situated on London’s Piccadilly, it shares a courtyard with the Royal Academy as well as four other “learned societies”. It’s an impressive building, and inside there is a great sense of scientific heritage, from the multitude of books that line the walls to the portraits of eminent chemists gazing down. It was here that I found myself on the 6th of February for an “In Silico Techniques” meeting of the Joint Pharmaceutical Analysis Group (JPAG).